Allergan takes a page from the Tea Party with social campaign

Share this article:
Allergan takes a page from the Tea Party with social campaign
Allergan takes a page from the Tea Party with social campaign
Allergan is launching a policy-focused social media campaign promoting its lap-band weight loss surgery with a populist tinge.

The Irvine, CA-based firm's “C.H.O.I.C.E.” campaign (“Choosing Health over Obesity Inspiring Change through Empowerment”) features a video contest for lap-band patients, the 12 winners of which will get an all-expenses-paid trip to Washington, DC – to lobby Congress for increased access to the surgery.

Allergan is asking visitors to campaign websites to sign a petition asking Congress to recognize that “Obesity is not a choice – it's a disease,” and that “With less invasive procedures available (like gastric banding), weight-loss surgery has the potential to be a catalyst for change in the health of our citizens and the financial stability of our healthcare system.” In particular, the campaign suggests that surgery may be the only path to permanent weight loss for 15 million “severely obese” Americans who are 100 pounds or more overweight.

“There's a lot of talk from Congress about obesity as a key threat,” said Cathy Taylor, senior manager, corporate communications at Allergan. “We're looking at Congress as a way to influence all parties,” including medical societies, healthcare professionals and consumers. The problem, said Taylor, isn't so much reimbursement as a need for national guidelines that recognize surgery as a treatment option for those patients.

The contest, dubbed the “Voice My C.H.O.I.C.E. Contest,” asks lap-band patients to submit a short essay or video about their weight-loss experience and how it has impacted their lives and health. The winners "will serve as a voice for those whose weight struggles continue and urge legislators to understand the importance of access to all effective treatments."

Allergan hopes to get 250,000 signatures on the petition, which “will be hand-delivered to legislators in September by a group of consumer advocates who will share their personal struggles and life-long journey of combating obesity.” The company will donate $250,000 to The George Washington University School of Public Health and Health Services' Department of Health Policy in support of its Strategies to Overcome and Prevent Obesity Alliance.

Campaign sites include and, along with a Facebook “Cause” and a Twitter feed. Chandler Chicco Agency is handling PR on the campaign, while InTouch Solutions is handling social media.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...